CTNS (gene)

Last updated

CTNS may also refer to the Center for Theology and the Natural Sciences.

Contents

CTNS
Identifiers
Aliases CTNS , CTNS-LSB, PQLC4, cystinosin, lysosomal cystine transporter, SLC66A4
External IDs OMIM: 606272 MGI: 1932872 HomoloGene: 3625 GeneCards: CTNS
Orthologs
SpeciesHumanMouse
Entrez

1497

83429

Ensembl

ENSG00000040531

ENSMUSG00000005949

UniProt

O60931

P57757

RefSeq (mRNA)

NM_031251
NM_001357891
NM_001357892

RefSeq (protein)

NP_112541
NP_001344820
NP_001344821

Location (UCSC) Chr 17: 3.64 – 3.66 Mb Chr 11: 73.07 – 73.09 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

CTNS is the gene that encodes the protein cystinosin in humans. Cystinosin is a lysosomal seven-transmembrane protein that functions as an active transporter for the export of cystine molecules out of the lysosome. [5]

Mutations in CTNS are responsible for cystinosis, an autosomal recessive lysosomal storage disease. [6]

Gene

The CTNS gene is located on the p arm of human chromosome 17, at position 13.2. [6] It spans base pairs 3,636,468 and 3,661,542, and comprises 12 exons. [6] [7]

In 1995, the gene was localized to the short arm of chromosome 17. [8] An international collaborative effort finally succeeded in isolating CTNS by positional cloning in 1998. [6]

The CTNSN323K, CTNSK280R, and CTNSN288K mutations completely stop the movement of CySS out of the lysosome via cystinosin.[2] interestingly, CTNSN323K and CTNSK280R are related to juvenile nephropathic cystinosis while CTNSN288K mutations are found in cases with infantile nephropathic cystinosis. [5]

Tissue distribution

The gene is expressed in the lysosomes of all organs and tissues. [9] Cystinosin has also been found in melanosomes in melanocytes. [10]

Structure

Cystinosin is a seven-transmembrane domain receptor embedded in the lysosomal membrane, and is a member of the lysosomal cystine transporter family of transport proteins. [11] It comprises 367 amino acid residues, and has a molecular mass of 41738 Da. [11] Cystinosin has seven N-glycosylation sites in the N-terminus region, spanning a range of 128 amino acid residues. [12]

The receptor also has two sorting motifs; a GYDQL motif in the C-terminus region, and a YFPQA motif, known as the 'PQ loop,' on the fifth inter-transmembrane α-helix moiety. [13]

Cystinosin embeds in the lysosomal membrane with the C-terminus region facing the cytosol and the N-terminus region facing the lumen. [14]

Mechanism

The protein obeys Michaelis-Menton kinetics and has an associated KM of 278 ± 49 μM. [12] [15]

The GYDQL and YFPQA motifs on the C-terminal binds cystinosin to the lysosome. Mutations in the GYDQL motif cause a repositioning of cystinosin to being partially on the plasma membrane and partially on the lysosome. Mutations in both GYDQL and YFPQA motifs cause cystinosin to position itself to the plasma membrane instead of lysosomes [14]

An increase in acidity in the lumen of the lysosome initiates the reaction of CySS and H+ being transported into the cytosol. [14]

Function

Cystinosin functions as a symporter which actively transports protons and cystine, the oxidized cysteine dimer, out of the lysosome. [12] Cystinosin only transports L-CySS while other cystine transporters will work on various amino acids. [14] If cystine builds up in the lysosome it will inhibit the normal functioning of the organelle making the transport function important in the regular functioning of cells.

Cystinosin has also been discovered in melanosomes and has been linked to the control and regulation of melanin. [10]

Clinical significance

Cystinosis

Mutations in CTNS gene can result in cystinosis. Cystinosis is a type of lysosomal transport disorder, a subset of lysosomal storage disorders. [16] Variation in the encoded cystinosin protein results in an inhibition or loss in its ability to transport cystine out of the lysosome. Cystine molecules accumulate and form crystals within the lysosome, impairing its function. [9]

Mutations

Cystinosis is presented in patients with a range of CTNS mutations; as of 2017, over 100 have been identified. [17] [18] The most common mutation is a 57,257 base pair deletion commonly referred to as the 57 kb deletion. This was formally known as the 65 kb deletion; a misnomer originating from early incorrect estimates. [19] [20] Other reported mutations include other deletions, missense mutations, and in-frame deletions and insertions. [21] [22]

The type and extent of mutation determines the type and severity of cystinosis in the carrier. [23] This is a result of the degree of transport inhibition caused by the misfolding of cystinosin. [21] For example, mild cystinosis is typically associated with mutations that do not affect the amino acids in the transmembrane domains of cystinosin. [7] In contrast, infantile nephropathic cystinosis, the most severe form of the disease, is most commonly associated with a total loss of activity. [21]

Gene deletion resulting in the absence of either of the sorting motifs results in the delocalization of cystinosin to the cellular plasma membrane. [24] [12]

Model systems

Human models for cystinosin are typically derived from cystinotic renal tubular cell lines. [25] [26]

Non-human protein homologs for cystinosin include ERS1 in Saccharomyces cerevisiae (yeast cells) and the Caenorhabditis elegans protein, C41C4.7. [27] Murine ctns has also been used. [28]

See also

Related Research Articles

<span class="mw-page-title-main">Lysosome</span> Cell membrane organelle

A lysosome is a single membrane-bound organelle found in many animal cells. They are spherical vesicles that contain hydrolytic enzymes that digest many kinds of biomolecules. A lysosome has a specific composition, of both its membrane proteins and its lumenal proteins. The lumen's pH (~4.5–5.0) is optimal for the enzymes involved in hydrolysis, analogous to the activity of the stomach. Besides degradation of polymers, the lysosome is involved in cell processes of secretion, plasma membrane repair, apoptosis, cell signaling, and energy metabolism.

<span class="mw-page-title-main">Cystinosis</span> Lysosomal storage disease

Cystinosis is a lysosomal storage disease characterized by the abnormal accumulation of cystine, the oxidized dimer of the amino acid cysteine. It is a genetic disorder that follows an autosomal recessive inheritance pattern. It is a rare autosomal recessive disorder resulting from accumulation of free cystine in lysosomes, eventually leading to intracellular crystal formation throughout the body. Cystinosis is the most common cause of Fanconi syndrome in the pediatric age group. Fanconi syndrome occurs when the function of cells in renal tubules is impaired, leading to abnormal amounts of carbohydrates and amino acids in the urine, excessive urination, and low blood levels of potassium and phosphates.

<span class="mw-page-title-main">Glucocerebrosidase</span> Mammalian protein found in humans

β-Glucocerebrosidase is an enzyme with glucosylceramidase activity that cleaves by hydrolysis the β-glycosidic linkage of the chemical glucocerebroside, an intermediate in glycolipid metabolism that is abundant in cell membranes. It is localized in the lysosome, where it remains associated with the lysosomal membrane. β-Glucocerebrosidase is 497 amino acids in length and has a molecular mass of 59,700 Da.

<span class="mw-page-title-main">NPC1</span> Protein-coding gene in the species Homo sapiens

Niemann-Pick disease, type C1 (NPC1) is a membrane protein that mediates intracellular cholesterol trafficking in mammals. In humans the protein is encoded by the NPC1 gene.

The epididymal secretory protein E1, also known as NPC2, is one of two main lysosomal transport proteins that assist in the regulation of cellular cholesterol by exportation of LDL-derived cholesterol from lysosomes. Lysosomes have digestive enzymes that allow it to break down LDL particles to LDL-derived cholesterol once the LDL particle is engulfed into the cell via receptor mediated endocytosis.

<span class="mw-page-title-main">LAMP2</span> Protein-coding gene in the species Homo sapiens

Lysosome-associated membrane protein 2 (LAMP2), also known as CD107b and Mac-3, is a human gene. Its protein, LAMP2, is one of the lysosome-associated membrane glycoproteins.

<span class="mw-page-title-main">Major facilitator superfamily</span>

The major facilitator superfamily (MFS) is a superfamily of membrane transport proteins that facilitate movement of small solutes across cell membranes in response to chemiosmotic gradients.

<span class="mw-page-title-main">LAMP1</span> Protein-coding gene in the species Homo sapiens

Lysosomal-associated membrane protein 1 (LAMP-1) also known as lysosome-associated membrane glycoprotein 1 and CD107a, is a protein that in humans is encoded by the LAMP1 gene. The human LAMP1 gene is located on the long arm (q) of chromosome 13 at region 3, band 4 (13q34).

<span class="mw-page-title-main">Sialin</span> Protein-coding gene in the species Homo sapiens

Sialin, also known as H(+)/nitrate cotransporter and H(+)/sialic acid cotransporter, is a protein which in humans is encoded by the SLC17A5 gene.

<span class="mw-page-title-main">AP3B1</span> Protein-coding gene in the species Homo sapiens

AP-3 complex subunit beta-1 is a protein that in humans is encoded by the AP3B1 gene.

<span class="mw-page-title-main">SCARB2</span> Protein-coding gene in the species Homo sapiens

Lysosomal integral membrane protein 2 (LIMP-2) is a protein that in humans is encoded by the SCARB2 gene. LIMP-2 is expressed in brain, heart, liver, lung and kidney, mainly in the membrane of lysosome organelles; however, in cardiac muscle, LIMP-2 is also expressed at intercalated discs. LIMP-2 in a membrane protein in lysosomes that functions to regulate lysosomal/endosomal transport. Mutations in LIMP-2 have been shown to cause Gaucher disease, myoclonic epilepsy, and action myoclonus–renal failure syndrome. Abnormal levels of LIMP-2 have also been found in patients with hypertrophic cardiomyopathy.

<span class="mw-page-title-main">AP3M1</span> Protein-coding gene in the species Homo sapiens

AP-3 complex subunit mu-1 is a protein that in humans is encoded by the AP3M1 gene.

<span class="mw-page-title-main">P2RX5</span> Protein-coding gene in the species Homo sapiens

P2X purinoceptor 5 is a protein that in humans is encoded by the P2RX5 gene.

<span class="mw-page-title-main">HPS3</span> Protein-coding gene in the species Homo sapiens

Hermansky–Pudlak syndrome 3 protein is a protein that in humans is encoded by the HPS3 gene.

<span class="mw-page-title-main">TAX1BP3</span> Protein-coding gene in the species Homo sapiens

Tax1-binding protein 3 is a protein that in humans is encoded by the TAX1BP3 gene. This name is in reference to the Tax1 protein of the Human T-cell Lymphotropic Virus (HTLV) which was used to discover Tax1BP3 in a yeast 2-hybrid screen and subsequently verified by co-IP. TIP1, as it is also known, is a PDZ domain containing protein. However, unlike most PDZ domain proteins which act as scaffolds and often contain multiple PDZ domains as well as other protein domains, TIP1 is essentially just the PDZ domain. This has led to the speculation that TIP1 acts as an inhibitor, either acting to separate PDZ binding motifs from their normal targets or simply preventing the protein to migrate away from the cytosol.

<span class="mw-page-title-main">VPS33B</span> Protein-coding gene in the species Homo sapiens

Vacuolar protein sorting-associated protein 33B is a protein that in humans is encoded by the VPS33B gene.

<span class="mw-page-title-main">TMEM106B</span> Protein-coding gene in the species Homo sapiens

Transmembrane protein 106B is a protein that is encoded by the TMEM106B gene. It is found primarily within neurons and oligodendrocytes in the central nervous system with its subcellular location being in lysosomal membranes. TMEM106B helps facilitate important functions for maintaining a healthy lysosome, and therefore certain mutations and polymorphisms can lead to issues with proper lysosomal function. Lysosomes are in charge of clearing out mis-folded proteins and other debris, and thus, play an important role in neurodegenerative diseases that are driven by the accumulation of various mis-folded proteins and aggregates. Due to its impact on lysosomal function, TMEM106B has been investigated and found to be associated to multiple neurodegenerative diseases.

<span class="mw-page-title-main">ABCA5</span> Protein-coding gene in the species Homo sapiens

ATP-binding cassette, sub-family A (ABC1), member 5 is a protein that in humans is encoded by the ABCA5 gene.

The lysosomal cystine transporter (LCT) family is part of the TOG Superfamily and includes secondary transport proteins that are derived from animals, plants, fungi and other eukaryotes. They exhibit 7 putative transmembrane α-helical spanners (TMSs) and vary in size between about 200 and 500 amino acyl residues, although most have between 300 and 400 residues.

A heme transporter is a protein that delivers heme to the various parts of a biological cell that require it.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000040531 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000005949 - Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 David D, Princiero Berlingerio S, Elmonem MA, Oliveira Arcolino F, Soliman N, van den Heuvel B, et al. (2019). "Molecular Basis of Cystinosis: Geographic Distribution, Functional Consequences of Mutations in the CTNS Gene, and Potential for Repair". Nephron. 141 (2): 133–146. doi: 10.1159/000495270 . PMID   30554218. S2CID   58767583.
  6. 1 2 3 4 Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, et al. (April 1998). "A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis". Nature Genetics. 18 (4): 319–324. doi:10.1038/ng0498-319. PMID   9537412. S2CID   10629789.
  7. 1 2 Shotelersuk V, Larson D, Anikster Y, McDowell G, Lemons R, Bernardini I, et al. (November 1998). "CTNS mutations in an American-based population of cystinosis patients". American Journal of Human Genetics. 63 (5): 1352–1362. doi:10.1086/302118. PMC   1377545 . PMID   9792862.
  8. ↑ "Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. The Cystinosis Collaborative Research Group". Nature Genetics. 10 (2): 246–248. June 1995. doi:10.1038/ng0695-246. PMID   7663525. S2CID   22093385.
  9. 1 2 Nesterova G, Gahl WA (January 2013). "Cystinosis: the evolution of a treatable disease". Pediatric Nephrology. 28 (1): 51–59. doi:10.1007/s00467-012-2242-5. PMC   3505515 . PMID   22903658.
  10. 1 2 Chiaverini C, Sillard L, Flori E, Ito S, Briganti S, Wakamatsu K, et al. (September 2012). "Cystinosin is a melanosomal protein that regulates melanin synthesis". FASEB Journal. 26 (9): 3779–3789. doi: 10.1096/fj.11-201376 . PMID   22649030. S2CID   11334825.
  11. 1 2 "Transporter Classification Database". www.tcdb.org. 2017-10-13. Archived from the original on 2014-01-03. Retrieved 2017-10-13.
  12. 1 2 3 4 Kalatzis V, Cherqui S, Antignac C, Gasnier B (November 2001). "Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter". The EMBO Journal. 20 (21): 5940–5949. doi:10.1093/emboj/20.21.5940. PMC   125690 . PMID   11689434.
  13. ↑ Andrzejewska Z, Névo N, Thomas L, Bailleux A, Chauvet V, Benmerah A, Antignac C (July 2015). "Lysosomal Targeting of Cystinosin Requires AP-3". Traffic. 16 (7): 712–726. doi: 10.1111/tra.12277 . PMID   25753619. S2CID   25009057.
  14. 1 2 3 4 Sumayao R, Newsholme P, McMorrow T (December 2018). "The Role of Cystinosin in the Intermediary Thiol Metabolism and Redox Homeostasis in Kidney Proximal Tubular Cells". Antioxidants. 7 (12): 179. doi: 10.3390/antiox7120179 . PMC   6315507 . PMID   30513914.
  15. ↑ Ruivo R, Bellenchi GC, Chen X, Zifarelli G, Sagné C, Debacker C, et al. (January 2012). "Mechanism of proton/substrate coupling in the heptahelical lysosomal transporter cystinosin". Proceedings of the National Academy of Sciences of the United States of America. 109 (5): E210–E217. doi: 10.1073/pnas.1115581109 . PMC   3277178 . PMID   22232659.
  16. ↑ Mancini GM, Havelaar AC, Verheijen FW (May 2000). "Lysosomal transport disorders". Journal of Inherited Metabolic Disease. 23 (3): 278–292. doi:10.1023/a:1005640214408. PMID   10863944. S2CID   19489712.
  17. ↑ Doneray H, Aldahmesh M, Yilmaz G, Cinici E, Orbak Z (June 2017). "Infantile Nephropathic Cystinosis: A Novel CTNS Mutation". The Eurasian Journal of Medicine. 49 (2): 148–151. doi:10.5152/eurasianjmed.2017.17039. PMC   5469843 . PMID   28638260.
  18. ↑ Owen EP, Nandhlal J, Leisegang F, Van der Watt G, Nourse P, Gajjar P (April 2015). "Common mutation causes cystinosis in the majority of black South African patients". Pediatric Nephrology. 30 (4): 595–601. doi:10.1007/s00467-014-2980-7. PMID   25326109. S2CID   22240586.
  19. ↑ Touchman JW, Anikster Y, Dietrich NL, Maduro VV, McDowell G, Shotelersuk V, et al. (February 2000). "The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion". Genome Research. 10 (2): 165–173. doi:10.1101/gr.10.2.165. PMC   310836 . PMID   10673275.
  20. ↑ Anikster Y, Lucero C, Touchman JW, Huizing M, McDowell G, Shotelersuk V, et al. (February 1999). "Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS)". Molecular Genetics and Metabolism. 66 (2): 111–116. doi:10.1006/mgme.1998.2790. PMID   10068513.
  21. 1 2 3 Kalatzis V, Nevo N, Cherqui S, Gasnier B, Antignac C (July 2004). "Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin". Human Molecular Genetics. 13 (13): 1361–1371. doi: 10.1093/hmg/ddh152 . PMID   15128704.
  22. ↑ Tang S, Danda S, Zoleikhaeian M, Simon M, Huang T (August 2009). "An Indian boy with nephropathic cystinosis: a case report and molecular analysis of CTNS mutation". Genetic Testing and Molecular Biomarkers. 13 (4): 435–438. doi:10.1089/gtmb.2008.0156. PMID   19580442.
  23. ↑ Attard M, Jean G, Forestier L, Cherqui S, van't Hoff W, Broyer M, et al. (December 1999). "Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin". Human Molecular Genetics. 8 (13): 2507–2514. doi: 10.1093/hmg/8.13.2507 . PMID   10556299.
  24. ↑ Cherqui S, Kalatzis V, Trugnan G, Antignac C (April 2001). "The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif". The Journal of Biological Chemistry. 276 (16): 13314–13321. doi: 10.1074/jbc.m010562200 . PMID   11150305.
  25. ↑ Racusen LC, Wilson PD, Hartz PA, Fivush BA, Burrow CR (August 1995). "Renal proximal tubular epithelium from patients with nephropathic cystinosis: immortalized cell lines as in vitro model systems". Kidney International. 48 (2): 536–543. doi: 10.1038/ki.1995.324 . PMID   7564123.
  26. ↑ Taub ML, Springate JE, Cutuli F (April 2011). "Reduced phosphate transport in the renal proximal tubule cells in cystinosis is due to decreased expression of transporters rather than an energy defect". Biochemical and Biophysical Research Communications. 407 (2): 355–359. doi:10.1016/j.bbrc.2011.03.022. PMID   21392501.
  27. ↑ Gao XD, Wang J, Keppler-Ross S, Dean N (May 2005). "ERS1 encodes a functional homologue of the human lysosomal cystine transporter". The FEBS Journal. 272 (10): 2497–2511. doi:10.1111/j.1742-4658.2005.04670.x. PMID   15885099. S2CID   13035448.
  28. ↑ Cherqui S, Sevin C, Hamard G, Kalatzis V, Sich M, Pequignot MO, et al. (November 2002). "Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis". Molecular and Cellular Biology. 22 (21): 7622–7632. doi:10.1128/MCB.22.21.7622-7632.2002. PMC   135682 . PMID   12370309.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.